Flublok Trivalent, 2026–2027 — 0.5 mL Prefilled Syringe, Pack of 10

Flublok® (Influenza Vaccine), 2026–2027 Formula

Recombinant trivalent influenza vaccine indicated for active immunization to prevent disease caused by the influenza A virus subtypes and influenza B virus represented by antigens contained in the vaccine. Approved for individuals 9 years of age and older. Each dose is 0.5 mL for intramuscular use.

Presentation

• Carton of ten 0.5 mL single-dose prefilled syringes

• Carton NDC: 49281-726-10

• Syringe NDC: 49281-726-88

• CPT code: 90673

• Rx only

Product attributes

• Recombinant hemagglutinin (HA) vaccine: 45 mcg per strain, 135 mcg total per 0.5 mL dose

• Contains no egg proteins, antibiotics, or preservatives

• Single-dose prefilled syringes contain no natural rubber latex

Storage and handling

• Store refrigerated at 2°C to 8°C (36°F to 46°F)

• Do not freeze; discard if frozen

• Protect syringes from light

• Do not use after the expiration date shown on the label

Always refer to the current prescribing information before use.